URGN
#2004
UroGen Pharma Ltd. - Ordinary Shares
39.8 7 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.74%
Monthly Change
+30.08%
6 month change
+103.00%
Year Change
+109.84%
Previous Close
39.1 9
Open
39.8 5
Low
39.1 6
High
40.2 0
Volume
597
Financials
- Market Capitalization 1.94 B
- Employee 291
- Founded 2004
- CEO N/A
- Website www.urogen.com
- Headquarter Israel
- FIGI N/A
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.34
Price to sales ratio
11.93
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2001 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -0.56% | +16.97% | +118.43% | 1.98 B USD | ||
| 2002 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 4.76 USD | +21.12% | +11.21% | +17.82% | +146.63% | 2.13 B USD | ||
| 2007 |  SION Sionna Therapeutics, Inc. - Common Stock | 44.36 USD | +4.16% | +0.82% | +23.19% | +12.76% | 2.00 B USD | ||
| 2013 |  NBTX Nanobiotix S.A. - ADSs | 39.76 USD | -4.51% | +2.47% | +12.32% | +654.46% | 1.92 B USD |
Frequently asked questions about UroGen Pharma Ltd. - Ordinary Shares
What is the UroGen Pharma Ltd. - Ordinary Shares stock price today?
The current price of UroGen Pharma Ltd. - Ordinary Shares (URGN) is 39.87. Over the past 24 hours, the stock has changed by +1.74%. Follow the URGN chart for real-time price dynamics.
What is the stock ticker of UroGen Pharma Ltd. - Ordinary Shares?
UroGen Pharma Ltd. - Ordinary Shares trades under the ticker URGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is UroGen Pharma Ltd. - Ordinary Shares stock going up?
URGN has changed by +4.84% over the last week, +30.08% over the last month, and +109.84% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was UroGen Pharma Ltd. - Ordinary Shares net income for the last quarter?
UroGen Pharma Ltd. - Ordinary Shares reported net income of -23.57 M for the last quarter. The previous quarter showed -26.36 M, which means net income changed by +10.58%.
How many employees does UroGen Pharma Ltd. - Ordinary Shares have?
As of the latest available data, UroGen Pharma Ltd. - Ordinary Shares has 291 employees. Workforce size can provide additional context about the company's scale and operations.
What is UroGen Pharma Ltd. - Ordinary Shares EBITDA?
UroGen Pharma Ltd. - Ordinary Shares EBITDA is -24.8 M, and its EBITDA margin is -53.02%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy UroGen Pharma Ltd. - Ordinary Shares stock?
You can buy UroGen Pharma Ltd. - Ordinary Shares (URGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in UroGen Pharma Ltd. - Ordinary Shares stock?
Investing in UroGen Pharma Ltd. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the URGN chart and related analysis on metatrader.com as part of your research.